glp 1 and inflammation GLP-1 drugs calm beyond diabetes weight loss Anti-Inflammatory Effects of GLP-1 Receptor

A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo

Nutrition in Clinical Practice, 27(2), 195200

The company's CT-388 dual agonist and CT-996 oral formulation are progressing through Phase II trials, with potential market entry expected by 2029

PMID: 91 AagndzDahinTYilmazBEkenciKDDuyar zerCapassoR

Reduced GSH levels shown by decreases in this ratioboth in the plasma and intracellularlyreflect intracellular shifts in oxidative burden and are indicative of immune dysfunction and progression of various disease states such as infection, sepsis, and age-related immune system decline ( GSH has also shown promise as a redox-based biomarker for neurodegenerative disease states

bretylium-like effect It can produce an initial pressor effect (due to tyramine & cocaine like actions), but later results in sympathoplegia (due to reserpine & bretylium like effects)